Artificial blood coming soon or never reaching clinical maturity?;Gibt es eine Zukunft für künstliche Blutersatzstoffe?

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 12, 2010, Pages 575-581

  Scholer M ^a   Frietsch, T ^b   Jambor, C ^c   Knels, R ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Institut Cottbus   (Germany)

Author keywords

Artificial blood; Artificial oxygen carriers; Hemoglobin based; Hypertension; Perfluorocarbon; Perfusion; Transfusion

Indexed keywords

ARTIFICIAL BLOOD; FLUOROCARBON; HEMOGLOBIN; PERFLEXANE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN;

BLOOD TRANSFUSION; HUMAN; HYPERTENSION; REVIEW; SHOCK; TREATMENT INDICATION;

EID: 77949696821     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1249214     Document Type: Review

References (49)

1. Adamson J G., Moore C. HemolinkTM, an o-raffinose crosslinked hemoglobin-based oxygencarrier. In: Chang TM (Ed) Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel Karger Landes Systems 1998 62-81
2. Carmichael F JL, Biro G P., Cheng D CH. Phase III Clinical Trial of HemolinkTM in Conjunction with intraoperative autologous blood donation (IAD) in cardiac surgical patients. In: Chang TMS (Ed) Eighth International Symposium of Blood Substitutes. New York Dekker, M Nov 09.-11., 2000 22
3. Conover C, Linberg R, Lejeune L, Gilbert C, Shum K, Shorr R G. Evaluation of the oxygen delivery ability of PEG-hemoglobin in Sprague- Dawley rats during hemodilution. Artif Cells Blood Substit Immobil Biotechnol 1998 26 199-212
4. Conover C D., Gilbert C W., Shum K L., Shorr R G. The impact of polyethylene glycol conjugation on bovine hemoglobins circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Artif Organs 1997 21 907-915
5. Doyle M P., Armstrong A M., Brucker E A., Fattor T J., Lemon D D. Design of a second generation recombinant hemoglobin: minimizing nitric oxide scavenging and vasoactivity while maintaining efficacy. In: Chang TM (Ed) Eighth International Symposium of Blood Substitutes. New York Dekker, M 2000
6. Frietsch T, Gassmann M, Groth G et al. Excessive erythrocytosis does not elevate capillary oxygen delivery in subcutaneous mouse tissue. Microcirculation 2007 14 111-123
7. Frietsch T, Lenz C, Waschke K F. Artificial Blood. In: Adams AP, Cashman JN (Ed) Recent advances in anaesthesia and analgesia. London Churchill Livingstone 2000 103-126
8. Frietsch T, Lenz C, Waschke K F. Künstliche Sauerstoffträger: Ein Update. Anaesth Intensivmed 2002 3 138-146
9. Gonzalez P, Hackney A C., Jones S et al. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study. J Investig Med 1997 45 258-264
10. Greenburg A G., Kim H W. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. J Am Coll Surg 2004 198 373-383; discussion 384375
11. Harris D R., Palmer A F. Novel strategies for transporting cellular hemoglobin- based oxygen carriers in the systemic circulation. TATM 2007 9 237-245
12. Hilarius P M., Escolar G, Gendreau M, Verhoeven A J. Mechanism of action of infusible platelet membranes. In: Chang TM (Ed) Eighth International Symposium of Blood Substitutes. New York Dekker, M Nov 09.-11.: 2000 34
13. Hill S E., Gottschalk L I., Grichnik K. Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002 16 695-702
14. Hsia C JC. Polynitroxylated haemoglobin (PNH): A new generation red cell substitute with vasodilatory and antioxidant properties. In: Chang TM (Ed) Eighth International Symposium of Blood Substitutes. New York Dekker, M 2000
15. Intaglietta M. Microcirculatory basis for the design of artificial blood. Microcirculation 1999 6 247-258
16. Kasper S M., Grune F, Walter M, Amr N, Erasmi H, Buzello W. The effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1998 87 284-291
17. Kim H W., Greenburg A G. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others. Artif Cells Blood Substit Immobil Biotechnol 2006 34 537-550
18. Komatsu H, Furuya T, Sato N et al. Effect of hemoglobin vesicle, a cellular-type artificial oxygen carrier, on middle cerebral artery occlusion- and arachidonic acid-induced stroke models in rats. Neurosci Lett 2007 421 121-125
19. Lamuraglia G M., Ohara P J., Baker W H. et al. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000 31 299-308
20. Leese P T., Noveck R J., Shorr J S., Woods C M., Flaim K E., Keipert P E. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth Analg 2000 91 804-811
21. Lenz C, Rebel A, Waschke K F., Koehler R C., Frietsch T. Blood viscosity modulates tissue perfusion sometimes and somewhere. Transfus Altern Transfus Med 2007 9 265-272
22. Mullon J, Giacoppe G, Clagett C, Mccune D, Dillard T. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. N Engl J Med 2000 342 1638-1643
23. Natanson C, Kern S J., Lurie P, Banks S M., Wolfe S M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: A Meta-analysis. JAMA 2008; 299: 2301-2312
24. Ning J, Wong L T., Christoff B, Carmichael F J., Biro G P. Haemodynamic response following a 10% topload infusion of HemolinkTM in conscious, anaesthetized and treated spontaneously hypertensive rats. Transfus Med 2000 10 13-22
25. Niquille M, Touzet M, Leblanc I, Baron J F. Reversal of intraoperative myocardial ischemia with a hemoglobin-based oxygen carrier. Anesthesiology 2000 92 882-885
26. Noveck R J., Shannon E J., Leese P T. et al. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Anesth Analg 2000 91 812-822
27. Panetta G, Arcovito A, Morea V, Bellelli A, Miele A E. Hb(alphaalpha,betabeta): A novel fusion construct for a dimeric, four-domain hemoglobin. Biochim Biophys Acta 2008 3 1462-1470
28. Pearce L B., Gawryl M S. Overview of preclinical and clinical efficacy of biopures HBOCs. In: Chang TM (Ed) Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel Karger Landes Systems 1998 82-100
29. Reynolds P S., Barbee R W., Ward K R. Lactate profiles as a resuscitation assessment tool in a rat model of battlefield hemorrhage resuscitation. Shock 2008 30 48-55
30. Rousselot M, Tsai A G., Intaglietta M, Zal F. Hemarina-M101 A new generation of blood substitutes coming from sea. In: Chang TM (Ed) Twelfth International Symposium of Blood Substitutes. Parma Aug 25-18., 2009 52-53
31. Sakai H, Sou K, Tsuchida E. Solution to the problems of acellular hemoglobins by encapsulation and the intrinsic issues of hemoglobin vesicles as a molecular assembly. TATM 2007 9 226-232
32. Sakai H, Yuasa M, Onuma H, Takeoka S, Tsuchida E. Synthesis and physicochemical characterization of a series of hemoglobin-based oxygen carriers: objective comparison between cellular and acellular types. Bioconjug Chem 2000 11 56-64
33. Saxena R, Wijnhoud A D., Carton H et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999 30 993-996
34. Sielenkamper A W., Eichelbronner O, Martin C M., Madorin S W., Chin-Yee I H., Sibbald W J. Diaspirin cross-linked hemoglobin improves mucosal perfusion in the ileum of septic rats. Crit Care Med 2000 28 782-787
35. Sloan E P., Koenigsberg M, Gens D et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. Jama 1999 282 1857-1864
36. Spahn D R., Van Brempt R, Theilmeier G et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology 1999 91 1195-1208
37. Spahn D R., Waschke R, Standl T et al. Use of perflurbron emulsion to decrease allogeneic blood transfusion in high-blood-loss non cardiac surgery: results of a European phase 3 study. Anesthesiology 2002 97 338-349
38. Spears J R., Wang B, Wu X et al. Aqueous oxygen: a highly O2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia. Circulation 1997 96 4385-4391
39. Sprung J, Kindscher J D., Wahr J A. et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth Analg 2002 94 799-808
40. Standl T, Horn P, Wilhelm S et al. Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can J Anaesth 1996 43 714-723
41. Tsai A, Cabrales P, Acharya A S., Intaglietta M. Resuscitation from hemorrhagic shock: recovery of oxygen carrying capacity of perfusion? Efficacy of new plasma expanders. Transfusion Alternatives in Transfusion Medicine 2007 9 246-253
42. Tsuchida E. Properties of and oxygen binding by albumin- tetraphenylporphyrinatoiron(II) derivative complexes. Bioconjug Chem 2000 11 56-64
43. Tsuchida E. Recent progress of artificial blood project and novel product. In: Chang TM (Ed) Eighth International Symposium of Blood Substitutes. New York Dekker, M Nov 09.-11., 2000 28
44. Tsuchida E, Komatsu T, Hamamatsu K et al. Exchange transfusion with albumin-heme as an artificial O2-infusion into anesthetized rats: physiological responses, O2-delivery, and reduction of the oxidized hemin sites by red blood cells. Bioconjug Chem 2000 11 46-50
45. Tyssebotn I, Bergoe G, Lundgren C. Intravascular perfluorocarbon- stabilized microbubbles for treatment of hypocemia due to an experimental intrapulmonary shunt. In: Chang TM (Ed) Eighth International Symposium of Blood Substitutes. San Diego 2000 102
46. Vandegriff K, Young M A., Keipert P, Winslow N. The safety profile of Hemospan: a new oxygewn therapeutic designed using maleimide poly(ethylene) glycol conjugation to human hemoglobin. TATM 2007 9 213-225
47. Von Dobschuetz E, Hoffmann T, Messmer K. Diaspirin cross-linked hemoglobin effectively restores pancreatic microcirculatory failure in hemorrhagic shock. Anesthesiology 1999 91 1754-1762
48. Wahr J A., Trouwborst A, Spence R K. et al. A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 1996 82 103-107
49. Winslow R M., Gonzales A, Gonzales M l et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 1998 85 993-1003